Algo version: 0.98b
Metropolis Healthcare is listed at the NSE Exchange
Metropolis Healthcare [METROPOLIS.NS]
NSE Sector: Healthcare Industry:Diagnostics & Research

Is Metropolis Healthcare stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Metropolis Healthcare pays dividends. Last time was Monday 4th of December 2023 where the investors holding the stock on Friday 17th of November 2023 were paid INR4 per share. Over the last 5 times between 2020 and 2023, Metropolis Healthcare has paid INR36 with an average of INR7.2 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Metropolis Healthcare 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was INR1 303.85, you would have made a profit of INR835.45 per share or 64.08%

Yes, the average daily trading liquidity for Metropolis Healthcare is INR159 664 thousand. You should therefore be able to get in and out of your positions relatively fast.

Metropolis Healthcare has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 0.69, the company's ability to pay off the debt is good. Metropolis Healthcare has a good net profit margin of 10.58% and should have high tolerances against inflation.

We have calculated the inflation risk for Metropolis Healthcare to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.